Mednax Inc Stock
Mednax Inc Stock
A loss of -1.740% shows a downward development for Mednax Inc.
For the coming years our community has positive and negative things to say abot the Mednax Inc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Mednax Inc in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mednax Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mednax Inc | -1.740% | 2.727% | 4.630% | 111.215% | 22.826% | 85.246% | -8.130% |
| Davita Inc. | -0.340% | 0.531% | 6.906% | 69.268% | 115.886% | 124.402% | 105.325% |
| Chemed Corp. | 2.670% | 5.000% | 13.793% | 28.333% | 26.923% | - | - |
| Molina Healthcare | 0.470% | -2.359% | -15.150% | 22.616% | 16.233% | -38.714% | -26.281% |
Comments
Pediatrix Medical Group (MD) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group (NYSE:MD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) was upgraded by analysts at Zacks Research to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat